Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Bayer Aktienges Ads (BAYRY)

Bayer Aktienges Ads (BAYRY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 59,123,672
  • Shares Outstanding, K 3,730,200
  • Annual Sales, $ 48,770 M
  • Annual Income, $ 4,582 M
  • 60-Month Beta 1.34
  • Price/Sales 1.30
  • Price/Cash Flow 4.52
  • Price/Book 1.62
Trade BAYRY with:
  • Price/Earnings ttm 8.84
  • Earnings Per Share ttm 1.78
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 02/25/21
  • Annual Dividend & Yield 0.53 (3.38%)
  • Most Recent Dividend 0.531 on 04/29/20
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate 0.40
  • Number of Estimates 1
  • High Estimate 0.40
  • Low Estimate 0.40
  • Prior Year 0.36
  • Growth Rate Est. (year over year) +11.11%

Price Performance

See More
Period Period Low Period High Performance
1-Month
14.5500 +4.19%
on 12/31/20
16.4000 -7.56%
on 01/21/21
+0.5700 (+3.91%)
since 12/24/20
3-Month
11.6500 +30.13%
on 10/30/20
16.4000 -7.56%
on 01/21/21
+2.8800 (+23.45%)
since 10/27/20
52-Week
11.6500 +30.13%
on 10/30/20
21.5075 -29.51%
on 02/06/20
-5.2820 (-25.84%)
since 01/27/20

Most Recent Stories

More News
Ophthalmic drugs Market Size Estimated to Surpass USD 37,700 Million By 2026, Globally: Facts & Factors

Facts and Factors have published a new research report titled "Ophthalmic Drug Market By Type (Over-the-Counter Drugs and Prescription Drugs), By Drug Class (Anti-inflammatory Drugs, Anti-Infective Drugs,...

AGN : 193.02 (+0.02%)
BAYRY : 15.1600 (-4.35%)
NVS : 92.90 (-3.17%)
PFE : 36.24 (-2.87%)
SNPHF : 16.5500 (+3.44%)
Smart Nanomaterials Market to Reach Value of USD 8.91 Billion by 2027 | Global Analysis, Industry Statistics, Revenue, Demand and Trend Analysis Research Report by Emergen Research

The global smart nanomaterials market is expected to reach a market size of USD 8.91 Billion by 2027, as a result of major R&D initiatives driving steady revenue growth, according to a current analysis...

ABT : 114.29 (-0.38%)
ALTI : 0.0800 (-20.00%)
BAYRY : 15.1600 (-4.35%)
Vascular Endothelial Growth Factor (VEGF) Inhibitor Market Realizes Product Innovation Through Robust R&D Activities And Strategic Collaborations

New year, new updates! Our reports have been revised for market size, forecasts, and strategies to take on 2021 after the COVID-19 impact: https://www.thebusinessresearchcompany.com/global-market-reports...

BAYRY : 15.1600 (-4.35%)
Bayer (BAYRY) Gets a Boost With Product Approvals and Deals

Bayer (BAYRY) gets a boost as it wins approvals for a few candidates and enters into collaboration agreements.

JNJ : 167.88 (-1.53%)
MRK : 77.07 (-3.96%)
BAYRY : 15.1600 (-4.35%)
ATRA : 18.78 (-3.99%)
Anophthalmia And Microphthalmia Market Size Is Projected to grow at a 5.8% CAGR By 2023

AERI : 18.19 (-0.33%)
AGN : 193.02 (+0.02%)
BAYRY : 15.1600 (-4.35%)
NVS : 92.90 (-3.17%)
PFE : 36.24 (-2.87%)
REGN : 515.56 (-5.25%)
SNPHF : 16.5500 (+3.44%)
VRX.TO : 30.80 (-3.33%)
Pharma Stock Roundup: FDA Nod to MRK, AZN, JNJ, GSK Drugs, LLY's New Antibody Deal

Merck (MRK), Glaxo (GSK), AstraZeneca (AZN) and J&J (JNJ) announce FDA approvals.

JNJ : 167.88 (-1.53%)
AZN : 52.10 (-4.30%)
MRK : 77.07 (-3.96%)
LLY : 207.57 (-2.42%)
GSK : 38.18 (-2.70%)
BAYRY : 15.1600 (-4.35%)
Insecticides Market Research 2021-2025|Industry Planning Structure for the New Normal|Technavio

--BASF SE, Bayer AG, and Corteva Inc. will emerge as major insecticides market participants during 2021-2025

BASFY : 19.1299 (-3.28%)
BAYRY : 15.1600 (-4.35%)
Smart Farming Market 2020-2024- Ag Leader Technology, AGCO Corp., Bayer AG, Among Others to Contribute to the Market Growth | Industry Analysis, Market Trends, Market Growth, Opportunities and Forecast 2024 | Technavio

The smart farming market is poised to grow by $ 2.17 bn during 2020-2024, progressing at a CAGR of almost 9% during the forecast period.

AGCO : 102.80 (-7.45%)
BAYRY : 15.1600 (-4.35%)
Topical Drug Delivery Market Size to Reach USD 145.68 Billion by 2027 | Asia Pacific is Estimated to Witness a CAGR of 7.8% in the global market, During the Forecast Period, States Emergen Research

The global Topical Drug Delivery market is estimated to reach value of USD 145.68 Billion by 2027, according to a current analysis by Emergen Research. The ability to bypass the first-pass metabolism of...

BAYRY : 15.1600 (-4.35%)
GSK : 38.18 (-2.70%)
MRK : 77.07 (-3.96%)
NSRGY : 116.8700 (+0.17%)
NVS : 92.90 (-3.17%)
Merck's (MRK) Heart Failure Drug Vericiguat Gets FDA Nod

Merck (MRK)/Bayer's (BAYRY) vericiguat gets FDA approval for symptomatic chronic heart failure and reduced ejection fraction

MRK : 77.07 (-3.96%)
NVS : 92.90 (-3.17%)
AMGN : 251.06 (-2.92%)
BAYRY : 15.1600 (-4.35%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Key Turning Points

3rd Resistance Point 15.4727
2nd Resistance Point 15.3613
1st Resistance Point 15.2607
Last Price 15.1600
1st Support Level 15.0487
2nd Support Level 14.9373
3rd Support Level 14.8367

See More

52-Week High 21.5075
Fibonacci 61.8% 17.7419
Fibonacci 50% 16.5788
Fibonacci 38.2% 15.4156
Last Price 15.1600
52-Week Low 11.6500

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar